 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other May 7 Calls Today's Calls |
| Call Details | |||
| AMERICAN ORIENTAL BIOENGR INC Earnings Conference Call (Q1 2008) Wed, May 7, 2008, 8:00 am Eastern
| |||
| About AMERICAN ORIENTAL BIOENGR INC (NYSE:AOB) | |||
| American Oriental Bioengineering, Inc., together with its subsidiaries, engages in the development, manufacture, and commercialization of a range of pharmaceutical and healthcare products. It offers prescription pharmaceutical products, over-the-counter pharmaceutical products, and nutraceutical products. The company’s prescription pharmaceutical products include Shuanghuanlian Lyophilized injection powder, an anti-viral injection for the treatment of flu symptoms, upper respiratory infections, mild pneumonia, and tonsillitis; and Cease Enuresis Soft Gel to alleviate pediatric bedwetting. Its over-the-counter pharmaceutical products comprise Cease Enuresis Patch for the treatment of bedwetting and incontinence; Jinji Capsule for the treatment of endometritis, annexitis, and pelvic inflammations; Jinji Yimucao for the treatment of premenstrual syndrome (PMS), and other PMS and menopause-related symptoms; and Boke nasal spray for the treatment of sinus congestion from common cold, stuffy nose, chronic rhinitis, allergic rhinitis, and nasosinusitis. The company’s nutraceutical products include soy peptide products series for overall health and well-being. It sells its products primarily to hospitals, clinics, pharmacies, and retail outlets in China. American Oriental Bioengineering has a strategic alliance with China Aoxing Pharmaceutical Co., Inc. to develop and commercialize narcotic and pain management products in China. The company is based in Shenzhen, the People’s Republic of China. | |||
More Info: | |||
